Nosis Bio
Updates & Highlights
Wilson Sonsini · 6 months ago
Wilson Sonsini Advises Nosis Bio on Strategic Collaboration and License Agreement with Johnson & Johnson
BioWorld News · about 1 year ago
Nosis Bio chooses first development candidate for fibrosis
Business Wire · about 1 year ago
Nosis Bio Announces Development Candidate Nomination for Lead Fibrosis Program
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Nosis Bio?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
8 recentWilson Sonsini Advises Nosis Bio on Strategic Collaboration and License Agreement with Johnson & Johnson
Wilson Sonsini Advises Nosis Bio on Strategic Collaboration and License Agreement with Johnson & Johnson
Wilson Sonsini · 6 months ago
Nosis Bio chooses first development candidate for fibrosis
Nosis Bio chooses first development candidate for fibrosis
BioWorld News · about 1 year ago
Nosis Bio Announces Development Candidate Nomination for Lead Fibrosis Program
Nosis Bio Announces Development Candidate Nomination for Lead Fibrosis Program
Business Wire · about 1 year ago
Daiichi Sankyo and Nosis Biosciences partner to advance RNA medicines
Daiichi Sankyo and Nosis Biosciences partner to advance RNA medicines
BioSpectrum Asia · over 1 year ago
Nosis Biosciences Announces Research Collaboration and Option Agreement with Daiichi Sankyo to Develop Cell-Targeted RNA Medicines
Nosis Biosciences Announces Research Collaboration and Option Agreement with Daiichi Sankyo to Develop Cell-Targeted RNA Medicines
Business Wire · over 1 year ago
Exclusive: Daiichi Sankyo, Johnson & Johnson partner with RNA delivery startup Nosis Bio
Exclusive: Daiichi Sankyo, Johnson & Johnson partner with RNA delivery startup Nosis Bio
Endpoints News · over 1 year ago
CF Foundation to fund Nosis Bio to design gene therapy carriers |...
CF Foundation to fund Nosis Bio to design gene therapy carriers |...
Cystic Fibrosis News Today · about 3 years ago
Executive Conversations with Nosis Bio and Vevo: Using Generative AI on AWS to Shift the Pharmaceutical R&D Paradigm | Amazon Web Services
Executive Conversations with Nosis Bio and Vevo: Using Generative AI on AWS to Shift the Pharmaceutical R&D Paradigm | Amazon Web Services
Amazon Web Services (AWS) · about 3 years ago